The global neurothrombectomy devices market size is expected to reach USD 1,051.3 million by 2028 according to a new study by Polaris Market Research. The report “Neurothrombectomy Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares); By End-Use (Hospitals, Emergency Clinics, Ambulatory Surgical Centers), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global aging population, increasing prevalence of heart related diseases due to faulty and busy lifestyle, favorable government support and funding towards research and innovation, and product launches by the key market players in the neurothrombectomy devices industry. As per statistics published by the World Ageing (WA), in 2019, there are around 700 million people aged over 65, across the globe.
This large section of the population is largely contributing to the market growth for neurothrombectomy devices. This section of the population is more prone to heart-related ailments. Moreover, as per CDC, each year, 480,000 smokers die prematurely. In 2018, it was reported that in the U.S. around 34.2 million smokers reside and many of those are suffering from heart-related disorders.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link: https://www.polarismarketresearch.com/industry-analysis/neurothrombectomy-devices-market/request-for-sample
Developed countries like the U.S. and Canada have witnessed a high prevalence of ischemic heart-related disorders. According to the estimates of the CDC, each year, on an average around 140,000 and 795,000 individuals in the U.S. die due to stroke. Also, product innovations to make the procedure less invasive by big players in the market also favoring the market growth for neurothrombectomy devices.
Similarly, as per the reports of the Stroke Report, in 2017, it was reported that around 400,000 people were suffering from long-term disability from heart stroke, and the number is expected to increase in the coming decade. Thus, the increasing prevalence of heart-related disorders is anticipated to be high impact rendering driver for the market for neurothrombectomy devices over the forecast period.
Neurothrombectomy devices industry participants include Medtronic, Stryker Corporation, Acandis GmbH, Stryker Corporation, Phenox GmbH, Penumbra Inc., and Vesalio are some of the key players operating in the market for neurothrombectomy devices. Companies in the market are focusing on product launches to retain their market dominance.
For instance, in September 2020, the U.S based entity of Johnson & Johnson Medical Devices Companies, CERENOVUS announced to introduce CERENOVUS Stroke Solutions. The services included in these three devices are designed to aid surgeons to effectively perform the clot removal process at the European Society of Minimally Invasive Neurological Therapy (ESMINT).
Heart attacks and strokes are the second leading cause of death across the globe, and it is being estimated that around 140,000 deaths occur in the U.S. alone every year. Around half of survivors become disabled and have an economic burden of around USD 34 billion on the healthcare facilities.
Polaris Market research has segmented the neurothrombectomy devices market report on the basis of product, end-use, and region:
Neurothrombectomy Devices, by Product Outlook (Revenue – USD Million, 2016 – 2028)
- Clot Retrievers
- Aspiration/Suction Devices
- Vascular Snares
Neurothrombectomy Devices, by End-Use Outlook (Revenue – USD Million, 2016 – 2028)
- Emergency Clinics
- Ambulatory Surgical Centers
Neurothrombectomy Devices, Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- Asia Pacific
- South Korea
- Central & South America
- Middle East & Africa
- Saudi Arabia
- South Africa